The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant docetaxel-cisplatin followed by concurrent chemoradiotherapy and adjuvant tislelizumab for locally advanced nasopharyngeal carcinoma: A multicenter, single-arm, phase II trial.
 
Yawei Yuan
No Relationships to Disclose
 
Yunhong Tian
Speakers' Bureau - Yunhong Tian
 
Huang Zhong
No Relationships to Disclose
 
Ronghui Zheng
No Relationships to Disclose
 
Lin Jie
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Kai Liao
No Relationships to Disclose
 
Jin Deng
No Relationships to Disclose
 
Yi Yu
No Relationships to Disclose
 
Wenze Qiu
No Relationships to Disclose
 
Junguo Bu
No Relationships to Disclose
 
Rong Zheng
No Relationships to Disclose
 
Benhua Xu
No Relationships to Disclose
 
Yong Chen
No Relationships to Disclose